Prevalence and Clinical Correlates of TIMI Flow Grade Zero Culprit-artery Occlusion in Patients with NSTEMI Undergoing Early Percutaneous Coronary Intervention

Najim, Raad Hassan; Taha, Mufeed Akram

doi:10.33091/amj.2026.170406.2635

	Prevalence and Clinical Correlates of TIMI Flow Grade Zero Culprit-artery Occlusion in Patients with NSTEMI Undergoing Early Percutaneous Coronary Intervention
Al- Anbar Medical Journal
Volume 22, Issue 3, July 2026, Pages 185-191 PDF (1.38 M)
Document Type: Original articles
DOI: 10.33091/amj.2026.170406.2635
Authors
Raad Hassan Najim¹; Mufeed Akram Taha^* ²
¹Department of Internal Medicine/Cardiology, College of Medicine, University of Kirkuk, Kirkuk, Iraq.
²Department of Internal Medicine/Neurology, College of Medicine, University of Kirkuk, Kirkuk, Iraq.
Abstract
Background: A substantial proportion of patients with non-ST-elevation myocardial infarction (NSTEMI) have an acutely occluded culprit artery despite the absence of diagnostic ST-segment elevation on the presenting electrocardiogram. Objective: To determine the prevalence of thrombolysis in myocardial infarction (TIMI) flow grade 0 total culprit-artery occlusion in percutaneous coronary intervention (PCI) treated NSTEMI and to identify its clinical, laboratory, echocardiographic, and angiographic correlates. Materials and Methods: This prospective single-center observational study included consecutive patients with NSTEMI who underwent coronary angiography within 24 hours of presentation and culprit-vessel PCI at Kirkuk Cardiac Centre, Iraq, from September 2023 to September 2025. NSTEMI was diagnosed by ischemic symptoms, absence of persistent ST-segment elevation, and cardiac troponin I above the 99^th-percentile upper reference limit (0.04 μg/L) with a serial rise/fall pattern. Patients were classified into the TIMI 0 and TIMI ≥1 groups based on pre-PCI culprit-vessel flow. Echocardiography was performed within 24 hours of admission and repeated before discharge. Group comparisons and multivariable logistic regression were performed. Results: Among 225 patients, TIMI 0 total occlusion was present in 78 (34.7%). Compared with TIMI ≥1, TIMI 0 was associated with male sex, higher body mass index (BMI), smoking, arrhythmia, family history of coronary artery disease, higher troponin, lower high-density lipoprotein (HDL) cholesterol, lower left ventricular ejection fraction, and more frequent left circumflex culprit lesions. In multivariable analysis, higher BMI, family history of coronary artery disease, higher admission troponin, lower HDL cholesterol, and lower admission ejection fraction remained independently associated with TIMI 0, whereas diabetes mellitus showed an inverse association. Conclusion: TIMI 0 total occlusion was common in PCI-treated NSTEMI and was associated with a distinct clinical and angiographic profile, including higher BMI and troponin levels, lower HDL cholesterol and left ventricular ejection fraction, and more frequent left circumflex culprit lesions.
Keywords
Non-ST elevated myocardial infarction; Coronary occlusion; Coronary angiography; Percutaneous coronary intervention; Myocardial infarction

References
[1] S. Savonitto et al., "Non-ST-segment elevation acute coronary syndrome: understanding the full spectrum to guide management," European Heart Journal, vol. 47, no. 4, pp. 423-437, 2025, doi: 10.1093/eurheartj/ehaf958. [2] A. R. Khan et al., "Impact of total occlusion of culprit artery in acute non-ST elevation myocardial infarction: a systematic review and meta-analysis," European Heart Journal, vol. 38, no. 41, pp. 3082-3089, 2017, doi: 10.1093/eurheartj/ehx418. [3] C.-S. Hung et al., "Prevalence and outcome of patients with non-ST segment elevation myocardial infarction with occluded “culprit” artery – a systemic review and meta-analysis," Critical Care, vol. 22, no. 1, p. 34, 2018/02/09 2018, doi: 10.1186/s13054-018-1944-x. [4] Q. Yu et al., "Impact of Acute Total Occlusion of the Culprit Vessel on Prognosis and Risk Stratification in Patients With Non-ST-Segment Elevation Myocardial Infarction," American Journal of Cardiology, vol. 254, pp. 139-146, 2025, doi: 10.1016/j.amjcard.2025.07.042. [5] R. Geffin, J. Triska, S. Najjar, J. Berman, M. Cruse, and Y. Birnbaum, "Why do we keep missing left circumflex artery myocardial infarctions?," Journal of Electrocardiology, vol. 83, pp. 4-11, 2024/03/01/ 2024, doi: https://doi.org/10.1016/j.jelectrocard.2023.12.011. [6] M. Ayyad et al., "Reevaluating STEMI: The Utility of the Occlusive Myocardial Infarction Classification to Enhance Management of Acute Coronary Syndromes," Current Cardiology Reports, vol. 27, no. 1, p. 75, 2025/03/27 2025, doi: 10.1007/s11886-025-02217-8. [7] A. M. Mohammad and M. M. Ali, "Prevalence and predictors of occlusive myocardial infarction in patients presenting with Non-ST-Elevation acute coronary syndrome in duhok, Iraq: a cross-sectional Study," Cureus, vol. 16, no. 7, 2024, doi: 10.7759/cureus.65299. [8] G. Sianos, M. I. Papafaklis, and P. W. Serruys, "Angiographic thrombus burden classification in patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention," Journal of invasive cardiology, vol. 22, no. 10, pp. 6B-14B, 2010. [9] R. A. Byrne et al., "2023 ESC Guidelines for the management of acute coronary syndromes: Developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC)," European Heart Journal. Acute Cardiovascular Care, vol. 13, no. 1, pp. 55-161, 2023, doi: 10.1093/ehjacc/zuad107. [10] S. V. Rao et al., "2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes," JACC, vol. 85, no. 22, pp. 2135-2237, 2025, doi: doi:10.1016/j.jacc.2024.11.009. [11] A. Güner et al., "Clinical implication of totally occluded infarct-related coronary artery in non-ST-segment elevation myocardial infarction: the TOTAL-NSTEMI study," Coronary Artery Disease, vol. 34, no. 2, pp. 127-133, 2023, doi: 10.1097/mca.0000000000001212. [12] B. Popovic et al., "Clinical Significance of Culprit Vessel Occlusion in Patients With Non–ST-Elevation Myocardial Infarction Who Underwent Percutaneous Coronary Intervention," The American Journal of Cardiology, vol. 188, pp. 95-101, 2023/02/01/ 2023, doi: https://doi.org/10.1016/j.amjcard.2022.11.013. [13] Y. H. Kim et al., "Three-Year Clinical Outcomes Based on Pre-Percutaneous Coronary Intervention Coronary Blood Flow Grade and Symptom-to-Balloon Time in Patients with Non-ST-Segment Elevation Myocardial Infarction," Journal of Clinical Medicine, vol. 12, no. 11, p. 3654, 2023, doi: https://doi.org/10.3390/jcm12113654. [14] Y. Wei, D. Pei, J. Deng, B. R. Sasmita, L. Mao, and F. Jia, "Clinical and Electrocardiographic Characteristics in NSTEMI Patients With Acute Total Occlusion of Culprit Left Circumflex Artery," Annals of Noninvasive Electrocardiology, vol. 30, no. 3, p. e70070, 2025, doi: https://doi.org/10.1111/anec.70070. [15] O. Kobo et al., "Prognosis of patients with left circumflex artery acute myocardial infarction in relation to ST-segment on admission electrocardiogram," European Heart Journal. Acute Cardiovascular Care, vol. 10, no. Supplement_1, 2021, doi: 10.1093/ehjacc/zuab020.077. [16] H. Pendell Meyers et al., "Accuracy of OMI ECG findings versus STEMI criteria for diagnosis of acute coronary occlusion myocardial infarction," IJC Heart & Vasculature, vol. 33, p. 100767, 2021/04/01/ 2021, doi: https://doi.org/10.1016/j.ijcha.2021.100767. [17] J. Komatsu et al., "Acute Left Circumflex Coronary Artery Occlusion　― Diagnostic Problems of Initial Electrocardiographic Changes ―," Circulation Reports, vol. 4, no. 10, pp. 482-489, 2022, doi: 10.1253/circrep.CR-22-0044. [18] Y. H. Kim et al., "Association of pre-percutaneous coronary flow grade and clinical outcomes in patients with non-ST-segment elevation myocardial infarction: Data from the Korea Acute Myocardial Infarction Registry," Medicine, vol. 100, no. 32, p. e26947, 2021, doi: 10.1097/md.0000000000026947. [19] M. Abusharekh et al., "Acute coronary occlusion with vs. without ST elevation: impact on procedural outcomes and long-term all-cause mortality," European Heart Journal - Quality of Care and Clinical Outcomes, vol. 10, no. 5, pp. 402-410, 2024, doi: 10.1093/ehjqcco/qcae003. [20] N. Fabin et al., "Early coronary revascularization among 'stable' patients with non-ST-segment elevation acute coronary syndromes: the role of diabetes and age," (in eng), Cardiovasc Res, vol. 120, no. 16, pp. 2064-2077, Dec 14 2024, doi: 10.1093/cvr/cvae190. [21] W. Huang, S. Flindy, A. Nurhafizah, K. A. Nafisa, A. Frederich, and J. W. Martha, "Percutaneous coronary intervention strategies in non-ST segment elevation acute coronary syndrome patients with multivessel coronary artery disease: Systematic review pairwise and network meta-analysis," (in eng), Cardiovasc Revasc Med, vol. 72, pp. 66-80, Mar 2025, doi: 10.1016/j.carrev.2024.10.009. [22] T. A. Kite et al., "Very early invasive strategy in higher risk non-ST-elevation acute coronary syndrome: the RAPID NSTEMI trial," Heart, vol. 110, no. 7, pp. 500-507, 2024, doi: https://doi.org/10.1136/heartjnl-2023-323513.
Statistics Article View: 277 PDF Download: 242